How Much Sulforaphane Per Day? What the Research Shows

Written and reviewed by Dr. Xiaoyan Qiu · June 2026

Most clinical studies land somewhere between 50 and 100 µmol of sulforaphane per day — roughly 9 to 18 mg — though the honest answer is a range, not a single number. That range shifts depending on two things: the dose a given study actually used, and how efficiently the precursor converts to sulforaphane in the body. Because sulforaphane is only formed when glucoraphanin meets the enzyme myrosinase — the chemistry we cover in how glucoraphanin converts to sulforaphane — the “dose” depends heavily on what form is being measured. This article lays out what doses clinical studies have actually used, how to translate the units researchers report into milligrams, and what changes the amount you need.

How Much Sulforaphane Per Day Do Studies Use?

Across the published human literature, doses cluster in a recognizable band. A comprehensive review of clinical trials found that protocols delivering sulforaphane directly ranged from 9.9 to 847 µmol per person per day, with a median of about 100 µmol, while those delivering its precursor glucoraphanin ranged from 25 to 800 µmol per day, median around 190 µmol.^[1] The frequently cited working figure of roughly 50–100 µmol of sulforaphane per day sits comfortably inside that band. One detail in those numbers is worth flagging immediately: the glucoraphanin doses trend higher than the sulforaphane doses. That is not arbitrary — it reflects the fact that precursor-based products convert incompletely without added myrosinase, so study designers compensate by giving more.^[1] It is the first sign that a dose figure means little until you know which compound it refers to. It also helps to remember that a daily figure is only half of a protocol. Most trials sustain a sulforaphane dosage for weeks to months, not as a one-off, because the mechanism depends on repeated activation rather than a single hit. So “how much per day” is really shorthand for “how much per day, for how long” — and the published answer is almost always a modest daily amount maintained consistently, rather than a large occasional one.

µmol or mg? Converting the Dose

The biggest source of confusion is units. Researchers almost always report doses in micromoles (µmol), because that reflects the actual number of molecules, while supplement labels and everyday questions are in milligrams (mg). The two are not interchangeable without a conversion, and the conversion differs between sulforaphane and glucoraphanin because they have different molecular weights. Using the molecular weights of sulforaphane (about 177 g/mol) and glucoraphanin (about 437 g/mol), the common research doses translate as follows. Note how the same µmol figure is a very different milligram amount depending on the compound. So when someone says a product provides “100” of something per day, the practical meaning swings from about 18 mg to about 44 mg purely based on which molecule is counted. Any dose claim that omits both the unit and the compound is incomplete. This is also why cross-product comparisons go wrong so easily. One label may advertise milligrams of glucoraphanin, another micromoles of sulforaphane, and a third “broccoli extract” with no compound named at all. Converted to a common basis, those numbers can rank in a completely different order than they appear on the shelf. The fix is to always reduce a claim to the same compound and the same unit before comparing — usually micromoles of sulforaphane delivered — so the comparison reflects chemistry rather than marketing.

From Glucoraphanin to Sulforaphane: The Dosing Math

This is where most dosing errors originate. A glucoraphanin dose is not the same as the sulforaphane it delivers, because conversion is partial. In a controlled phase I study, the fraction of an administered dose recovered as absorbed isothiocyanate metabolites was around 70% when sulforaphane itself was given, but only roughly 18–20% when the glucosinolate precursor was given without active enzyme.^[2] In other words, a large share of a precursor-only dose is simply never converted. That gap is exactly why study designers use higher glucoraphanin numbers, and why a “milligrams of glucoraphanin” figure on a label tells you the ceiling, not the delivered amount. When glucoraphanin is paired with active myrosinase, however, conversion becomes far more efficient and predictable^[4] — which is why the single most important question behind any sulforaphane dose is whether the conversion enzyme is present. A worked example makes the logic concrete. Suppose the target is the ~100 µmol sulforaphane median seen in studies. From a myrosinase-active source, you would aim for roughly 100 µmol of glucoraphanin (about 44 mg), because most of it converts. From a myrosinase-inactivated precursor relying on gut bacteria, you might need several times that to land the same delivered amount, since only a fraction converts. The starting number looks similar; the input required to hit the target does not.

Once a Day or Split Into Two?

Most clinical protocols dose once daily, but timing has been studied directly. In one trial, subjects took 200 µmol of sulforaphane equivalents per day either as a single dose or as two 100-µmol doses twelve hours apart; the split schedule was examined specifically for its effect on how long sulforaphane stayed available in the body.^[3] Because sulforaphane is cleared relatively quickly, dividing a dose can help maintain exposure across the day rather than producing one sharp peak. What you will not find much support for is weekly dosing. People sometimes ask about taking a sulforaphane supplement weekly, but the human studies are built around daily intake, often for weeks or months, and the compound’s short half-life makes a once-a-week approach a poor fit for sustained effect. If consistency matters, daily — or twice-daily — is what the evidence is based on. The takeaway on frequency is simple: match the schedule to the biology. Because sulforaphane is absorbed and cleared within hours rather than days, steady daily exposure is what the trials were designed to produce. Splitting a daily amount can smooth that exposure; stretching it to weekly intervals largely defeats the purpose. Frequency, in other words, is part of the dose — not a separate convenience decision.

Does the Form Change the Dose You Need?

Yes, and this is the practical trap in comparing products. Two items can list the same nominal dose and deliver very different amounts of actual sulforaphane. In a head-to-head human comparison, fresh broccoli sprouts produced roughly three times higher sulforaphane metabolite levels than a supplement delivering the same labeled amount, because of differences in myrosinase activity.^[3] This means a dose figure is only meaningful alongside the form. A myrosinase-active preparation, a myrosinase-inactivated precursor relying on gut bacteria, and a pre-formed stabilized sulforaphane will each require a different label number to land the same delivered dose. Reading the amount without reading the form is how two buyers end up with the same specification on paper and very different results in practice. For that reason, setting a sulforaphane supplement dosage is really a two-part decision: the delivered target you want, and the form-specific input needed to reach it. The same finished dose can come from a smaller myrosinase-active amount or a larger inactivated one, and the two are not interchangeable on the label. Specifying the delivered amount, then choosing the input to match the chosen form, is the only way to make the number mean the same thing across products.

Is There a Safe Upper Limit, and Are There Side Effects?

Formal tolerance work exists. A placebo-controlled phase I study administered broccoli sprout preparations at defined doses every eight hours for seven days and reported no systematic, clinically significant adverse effects in healthy volunteers.^[2] Higher amounts — up to several hundred micromoles per day — have been used in other trials, which is how the upper end of the reported range reaches into the hundreds.^[1] That said, “studied without significant adverse effects” is not the same as a recommended dose, and tolerability varies between individuals; the most commonly reported side effects of sulforaphane are mild digestive complaints. None of this is medical advice, and anyone weighing a specific intake — particularly alongside medications or health conditions — should consult a qualified professional rather than self-prescribe from a research range. It is also worth noting that the upper-end research doses were used under study supervision, not as everyday self-dosing, and that more is not a goal in itself. Because the body’s response is not strictly proportional to the amount taken, pushing toward the top of the reported range offers no guaranteed benefit and simply raises the chance of mild discomfort. The pattern across the literature points toward a moderate, consistent daily amount rather than the largest tolerable one.

What Is Sulforaphane Studied For?

The reason dosing attracts so much attention is sulforaphane’s mechanism, which is also what people are really asking when they search what is sulforaphane good for: it activates the Keap1–Nrf2–ARE pathway, switching on the body’s own phase II detoxification and antioxidant genes rather than acting as a direct antioxidant.^[5] Reviews also note its dose–response can be non-linear, so more is not automatically better.^[5] Beyond mechanism, sulforaphane has been examined across a broad set of research areas — including detoxification biomarkers and, in early or preliminary work, areas such as Helicobacter pylori, certain cancers, and neurodevelopmental conditions. These remain active areas of investigation rather than settled outcomes, and they are noted here only to explain the research context — not as health claims for any product. The practical relevance to dosing is simply that the doses described above are the ones these investigations have used, which is why they anchor the discussion.

Getting a Reproducible Dose

Pulling it together: a defensible sulforaphane dose requires three pieces of information — the compound (sulforaphane or glucoraphanin), the unit (µmol or mg), and the form (myrosinase-active, inactivated, or pre-formed). Food cannot supply any of these reliably, because content swings with cultivar and cooking, as covered in our guide to foods highest in sulforaphane. That variability is fine for eating but useless for a specification. A standardized ingredient closes the gap. A standardized bulk broccoli extract that states its glucoraphanin percentage by HPLC and its myrosinase status per batch lets a formulator calculate the per-serving dose forward in both µmol and mg, rather than estimating it from a variable food or an underspecified label. The chemistry is identical to the kitchen; the difference is that the numbers are documented and repeatable. For a finished product, that repeatability is what turns a dose from a marketing figure into a defensible claim. A batch with a known glucoraphanin percentage can be translated directly into micromoles, then into the milligram amount per capsule or serving, then checked against the research range — every step traceable. The food-versus-supplement debate is, in the end, less about which is “better” and more about which can be specified: for everyday eating, food is fine; for a number you have to stand behind, a documented extract is what makes the answer to “how much sulforaphane per day” something you can actually prove.

Frequently Asked Questions

References